The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer

[1]  G. Browman,et al.  Science, language, intuition, and the many meanings of quality of life. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H Sakai,et al.  A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. , 1998, European journal of cancer.

[3]  Aaronson Nk.  Assessing the quality of life of patients with cancer: east meets west. , 1998 .

[4]  C. Nagata,et al.  Choice of response scale for health measurement: comparison of 4, 5, and 7-point scales and visual analog scale. , 1996, Journal of epidemiology.

[5]  S. Kaasa,et al.  The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. , 1995, European journal of cancer.

[6]  D. Osoba.  Lessons learned from measuring health-related quality of life in oncology. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Ganz,et al.  Predicting Psychosocial Risk in Patients With Breast Cancer , 1993, Medical care.

[8]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[9]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Cella,et al.  Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials , 1992, Quality of Life Research.

[11]  K. Eguchi,et al.  Feasibility study on quality-of-life questionnaires for patients with advanced lung cancer. , 1992, Japanese journal of clinical oncology.

[12]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[13]  C. Moinpour,et al.  Quality of life end points in cancer clinical trials: review and recommendations. , 1989, Journal of the National Cancer Institute.

[14]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[15]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Kudoh,et al.  Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese , 2004, Quality of Life Research.

[17]  K. Kobayashi.  [Development of QOL questionnaires in Japan]. , 1999, Gan to kagaku ryoho. Cancer & chemotherapy.

[18]  N. Aaronson.  Assessing the quality of life of patients with cancer: east meets west. , 1998, European journal of cancer.

[19]  B. Gandek,et al.  MAP-R for windows: multitrait / multi-item analysis program - revised user's guide. , 1997 .

[20]  D. Machin.  Assessment of quality of life in clinical trials of the British Medical Research Council. , 1996, Journal of the National Cancer Institute. Monographs.

[21]  D. Tulsky,et al.  Quality of life in cancer: definition, purpose, and method of measurement. , 1993, Cancer investigation.

[22]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[23]  N. Aaronson,et al.  A modular approach to quality-of-life assessment in cancer clinical trials. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.